Search
Collegium Pharmaceutical Inc
COLLAdd to Watchlist
23.230USD
+0.220+0.96%
Close 10-20 16:00（ET）
753.35MMarket Cap
9.86P/E TTM
Collegium Pharmaceutical Inc (COLL) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Collegium Pharmaceutical Inc in the past month.
Buy
3 Strong Buy
4 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
49.000USD+111.30%
COLL Analyst Recommendation Trends
In the current month, COLL has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. COLL average Analyst price target in the last month is 49.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
3
1
1
1
1
1
1
4
4
4
4
4
4
4
4
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
6
6
6
6
6
6
COLL Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
Financial Forecasting
Based on analysts' estimates, COLL EPS is projected to reach 1.798 in FY2026Q3, following reported EPS of -0.464 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.33
1.59
1.72
1.80
1.91
Actual
0.54
0.45
-0.46
--
--
Surprise
-76.98%
-71.61%
-127.03%
--
--
FAQs
What is Collegium Pharmaceutical Inc's expected revenue for the next quarter?
Collegium Pharmaceutical Inc's expected revenue is 217.69M.
What is Collegium Pharmaceutical Inc's price target?
Analysts forecast that Collegium Pharmaceutical Inc's price target is USD 49.00, with the highest forecast at USD 60.00 and the lowest forecast at USD 43.00.
How have Collegium Pharmaceutical IncCOLL's recent earnings per share performed?
The market expectation was USD -0.46, while Collegium Pharmaceutical IncCOLL's earnings per share (EPS) for the previous quarter was USD 0.45. EPS for the next quarter is expected at USD 1.80.
What is the analyst rating for Collegium Pharmaceutical Inc?
Based on the ratings of Collegium Pharmaceutical Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.